ArticleFrontiers in oncology2023

Development and validation of a nomogram to evaluate the therapeutic effects of second-line axitinib in patients with metastatic renal cell carcinoma.

Dengqiang Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.